Transdermal Methylphenidate for Cancer-Related Fatigue
Status:
Withdrawn
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects, good and/or bad, of the Methylphenidate
patch and a placebo patch (a patch that contains no medicine) on patients and their fatigue
caused by cancer or by cancer treatment. The Methylphenidate patch contains a medication that
is known to increase alertness and wakefulness. Oral methylphenidate has been used in the
past to treat cancer related fatigue and is often used to treat unusual sleepiness. But this
is the first time that the patch form is offered to try treating cancer fatigue in patients
who cannot always swallow tablets.